<?xml version="1.0" encoding="UTF-8"?>
<p>Studies included in the present review suggested that different medicinal cannabinoids at distinct doses and formulations could represent promising treatment strategies for PTSD-related symptoms, also presenting an impact on the quality of life in this population. Particularly, not only did treatment with cannabinoids determine an overall improvement of PTSD symptomatology [
 <xref rid="B37-life-11-00214" ref-type="bibr">37</xref>,
 <xref rid="B39-life-11-00214" ref-type="bibr">39</xref>,
 <xref rid="B40-life-11-00214" ref-type="bibr">40</xref>,
 <xref rid="B47-life-11-00214" ref-type="bibr">47</xref>,
 <xref rid="B48-life-11-00214" ref-type="bibr">48</xref>,
 <xref rid="B49-life-11-00214" ref-type="bibr">49</xref>,
 <xref rid="B51-life-11-00214" ref-type="bibr">51</xref>], but it also influenced specific symptom domains, namely sleep disorders [
 <xref rid="B37-life-11-00214" ref-type="bibr">37</xref>,
 <xref rid="B38-life-11-00214" ref-type="bibr">38</xref>,
 <xref rid="B39-life-11-00214" ref-type="bibr">39</xref>], arousal disturbances [
 <xref rid="B37-life-11-00214" ref-type="bibr">37</xref>], and suicidal thoughts [
 <xref rid="B48-life-11-00214" ref-type="bibr">48</xref>]. Noteworthy, a significant reduction of pain [
 <xref rid="B48-life-11-00214" ref-type="bibr">48</xref>,
 <xref rid="B51-life-11-00214" ref-type="bibr">51</xref>] and social impact [
 <xref rid="B48-life-11-00214" ref-type="bibr">48</xref>], as well as an improvement in quality of life and well-being [
 <xref rid="B39-life-11-00214" ref-type="bibr">39</xref>,
 <xref rid="B51-life-11-00214" ref-type="bibr">51</xref>], were demonstrated.
</p>
